According to a report published by Grand View Research, Inc., the respiratory syncytial virus (RSV) diagnostics market is likely to reach a valuation of around USD 1.2 billion by 2022. Rising prevalence of respiratory infections, increasing infant population, high demand for in-vitro diagnostics, and growing demand for point of care facilities can drive the market over the... Continue Reading →